Jüvenil Miyoklonik Epilepsi
Özet
Jüvenil miyoklonik epilepsi, ergenlik döneminde başlayan, genellikle uykudan uyanma sonrası görülen miyoklonik nöbetler ve jeneralize tonik-klonik kasılmalarla karakterize, genetik kökenli bir epilepsi sendromudur. Uyku yoksunluğu ve stres gibi faktörlerle tetiklenen bu durum, elektroensefalografide spesifik diken-dalga paternleri ile teşhis edilir. Tedavisinde yaşam tarzı düzenlemeleri temel yer tutarken, valproat gibi ilaçlar ilk seçenek olarak değerlendirilmekle birlikte, özellikle doğurganlık çağındaki kadınlarda yan etkiler nedeniyle dikkatli yönetilmelidir. Hastaların büyük çoğunluğu uygun tedaviyle nöbetsiz bir yaşam sürebilse de, bazı vakalarda ilaca direnç ve psikososyal zorluklar devam edebilmektedir.
Juvenile myoclonic epilepsy is a genetic epilepsy syndrome characterized by myoclonic jerks, often occurring upon awakening, alongside generalized tonic-clonic seizures in adolescents. This condition, frequently triggered by factors like sleep deprivation and stress, is diagnosed through specific spike-and-wave patterns observed in electroencephalography. While lifestyle adjustments and pharmacological treatments, primarily valproate, are essential for seizure control, management in women of childbearing age requires caution due to potential side effects. Although most patients achieve seizure freedom with appropriate care, some cases present with drug resistance and persistent psychosocial challenges.
Referanslar
Janz D, Christian W. Impulsive-petit mal. Deutsche Zeitschrift für Nerven-heilkunde 1957;176:346-388.
Lund M, Reintoft H, Simonsen N. A controlled sociological and psychological study on patients with juvenile myoclonus epilepsy. Nervenarzt. 1976;47(12):708-712.
Asconapé J, Penry JK. Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia. 1984;25(1):108-114.
Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984;34(3):285-294.
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30(4):389-399.
Genton P, Gelisse P, Thomas P. Juvenile myoclonic epilepsy today: current definitions and limits. In: Schmitz B, Sander T, editors. Juvenile myoclonic epilepsy. The Janz syndrome. Petersfıeld: Wringhtson Biomedial Publishing; 2000.p.11-32.
Montalenti E, Imperiale D, Rovera A, Bergamasco B, Benna P. Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients. J Neurol Sci. 2001;184(1):65-70.
Wheless JW, Kim HL. Adolescent seizures and epilepsy syndromes. Epilepsia. 2002;43 Suppl 3:33-52.
Kasteleijn-Nolst Trenité DG, Schmitz B, Janz D, et al. Consensus on diagnosis and management of JME: From founder's observations to current trends. Epilepsy Behav. 2013;28(Suppl 1):S87-S90.
Hirsch E, French J, Scheffer IE, Zuberi SM, Trinka E, Specchio N, et al. (2017-2021). ILAE Definition of the Idiopathic Generalized Epilepsy Syndromes: Position Statement by the ILAE Task force on Nosology and Definitions. ILAE Draft guideline (https://www.ilae.org/files/dmfile/IGEFINALApril2.pdf)
Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand. 1985;72(5):449-459.
Usui N, Kotagal P, Matsumoto R, Kellinghaus C, Lüders HO. Focal semiologic and electroencephalographic features in patients with juvenile myoclonic epilepsy. Epilepsia. 2005;46(10):1668-1676.
Panayiotopoulos CP, Obeid T, Waheed G. Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study. Ann Neurol. 1989;25(4):391-397.
Wolf P, Yacubian EM, Avanzini G, et al. Juvenile myoclonic epilepsy: A system disorder of the brain. Epilepsy Res. 2015;114:2-12.
Matsuoka H, Takahashi T, Sasaki M, et al. Neuropsychological EEG activation in patients with epilepsy. Brain. 2000;123 (2):318-330.
Mayer TA, Schroeder F, May TW, Wolf PT. Perioral reflex myoclonias: a controlled study in patients with JME and focal epilepsies. Epilepsia. 2006;47(6):1059-1067.
Guaranha MS, da Silva Sousa P, de Araújo-Filho GM, et al. Provocative and inhibitory effects of a video-EEG neuropsychologic protocol in juvenile myoclonic epilepsy. Epilepsia. 2009;50(11):2446-2455.
Guaranha MS, Filho GM, Lin K, Guilhoto LM, Caboclo LO, Yacubian EM. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure. 2011;20(1):42-48.
Martínez-Juárez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain. 2006;129(5):1269-1280.
De Araujo Filho GM, Yacubian EM. Juvenile myoclonic epilepsy: psychiatric comorbidity and impact on outcome. Epilepsy Behav. 2013;28 (Suppl 1):S74-S80.
Schmitz B, Yacubian EM, Feucht M, Hermann B, Trimble M. Neuropsychology and behavior in juvenile myoclonic epilepsy. Epilepsy Behav. 2013;28 (Suppl 1):S72-S73.
Walsh J, Thomas RH, Church C, Rees MI, Marson AG, Baker GA. Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy. Epilepsy Behav. 2014;35:72-77.
Shahnaz, Sher K, Abdul Sattar R. Clinical and EEG characteristics of Juvenile Myoclonic Epilepsy. Pak J Med Sci. 2014;30(1):12-15.
Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia. 1994;35(2):285-296.
Greenberg DA, Durner M, Resor S, Rosenbaum D, Shinnar S. The genetics of idiopathic generalized epilepsies of adolescent onset: differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal. Neurology. 1995;45(5):942-946.
Delgado-Escueta AV, Koeleman BP, Bailey JN, Medina MT, Durón RM. The quest for juvenile myoclonic epilepsy genes. Epilepsy Behav. 2013;28 (Suppl 1):S52-S57.
Santos BPD, Marinho CRM, Marques TEBS, et al. Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies. PLoS One. 2017;12(6):e0179629.
Jayalakshmi SS, Srinivasa Rao B, Sailaja S. Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy. Acta Neurol Scand.2010;122(2):115-123.
Bauer PR, Gorgels K, Spetgens W, et al. The topographical distribution of epileptic spikes in juvenile myoclonic epilepsy with and without photosensitivity. Clin Neurophysiol. 2017;128(1):176-182.
Cao B, Tang Y, Li J, Zhang X, Shang HF, Zhou D. A meta-analysis of voxel-based morphometry studies on gray matter olüme alteration in juvenile myoclonic epilepsy. Epilepsy Res. 2013;106(3):370-377.
Aydin-Ozemir Z, Terzibasioglu E, Altindag E, Sencer S, Baykan B. Magnetic resonance spectroscopy findings in photosensitive idiopathic generalized epilepsy. Clin EEG Neurosci. 2010;41(1):42-49.
Koepp MJ, Woermann F, Savic I, Wandschneider B. Juvenile myoclonic epilepsy neuroimaging findings. Epilepsy Behav. 2013;28( Suppl 1):S40-S44.
Vollmar C, O'Muircheartaigh J, Barker GJ, et al. Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study. Brain. 2011;134(6):1710-1719.
Vollmar C, O’Muircheartaigh J, Symms MR, et al. Altered microstructural connectivity in juvenile myoclonic epilepsy: the missing link. Neurology. 2012;78(20):1555-1559.
Kim JH. Grey and White Matter Alterations in Juvenile Myoclonic Epilepsy: A Comprehensive Review. J Epilepsy Res. 2017;7(2):77-88.
Kim SH, Lim SC, Kim W, et al. Extrafrontal structural changes in juvenile myoclonic epilepsy: a topographic analysis of combined structural and microstructural brain imaging. Seizure. 2015;30:124-131.
Swartz BE, Spitz J, Vu AL, Mandelkern M, Su ML. Heterogeneity of anatomic regions by MR volumetry in juvenile myoclonic epilepsy. Acta Neurol Scand. 2016;134(4):300-308.
Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia. 1989;30 (Suppl 4):S19-S27.
Kverneland M, Selmer KK, Nakken KO, Iversen PO, Taubøll E. A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy. Epilepsy Behav. 2015;53:197-201.
Brodie MJ. Modern management of juvenile myoclonic epilepsy. Expert Rev Neurother. 2016;16(6):681-688.
Hernández-Vanegas LE, Jara-Prado A, Ochoa A, et al. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high. Epilepsy Behav. 2016;61:34-40.
Tomson T, Marson A, Boon P, et al. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56(7):1006-1019.
Tomson T, Battino D, Bonizzoni E, et al. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP. Epilepsia. 2016;57(8):e173-e177.
Martinović Z. Adjunctive behavioural treatment in adolescents and young adults with juvenile myoclonic epilepsy. Seizure. 2001;10(1):42-47.
Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry.2001;70(2):240-243.
Senf P, Schmitz B, Holtkamp M, Janz D. Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors. Neurology. 2013;81(24):2128-2133.
Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology. 2009;73(13):1041-1045.
Geithner J, Schneider F, Wang Z, et al. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia. 2012;53(8):1379-1386.
Yacubian EM. Juvenile myoclonic epilepsy: Challenges on its 60th anniversary. Seizure. 2017;44:48-52.
Baykan B, Wolf P. Juvenile myoclonic epilepsy as a spectrum disorder: A focused review. Seizure. 2017;49:36-41.
